HIV-1 nef, Clade B

HIV-1 nef Clade B Recombinant
Cat. No.
BT22006
Source
Escherichia Coli.
Synonyms
Appearance
Sterile Filtered and lyophilized, though might appear as a solution as a result of the glycerol content.
Purity
Greater than 90.0% as determined by HPLC analysis and SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

The E.coli derived 27 kDa recombinant HIV-1 Nef Clade-B protein is a single non-glycosylated polypeptide chain.

Product Specs

Introduction
The HIV-1 Nef protein, weighing 27kDa, is abundantly produced shortly after viral infection. It plays a critical role in viral replication and the progression of the disease. Nef enhances the efficiency of viral replication and increases the infectivity of virions. It exhibits diverse effects, including the downregulation of MHC-I molecules on the cell surface and a decrease in surface CD4 antigen levels. This reduction in CD4 is achieved through interaction with the LCK tyrosine kinase, leading to the dissociation of the LCK-CD4 complex and promoting clathrin-dependent endocytosis of CD4, ultimately targeting it for lysosomal degradation. Nef also protects infected cells from apoptosis, ensuring their survival until the next generation of viruses is ready. Additionally, the Nef protein interferes with host T-cell signaling, initiating a transcriptional program remarkably similar to that triggered by anti-CD3 cell activation.
Description
This recombinant HIV-1 Nef protein, derived from E. coli and representing Clade-B, is a single, non-glycosylated polypeptide chain with a molecular weight of 27 kDa.
Physical Appearance
While typically supplied as a sterile filtered and lyophilized powder, the presence of glycerol may give it a solution-like appearance.
Formulation

Lyophilized with a 1% glycerol concentration.

Solubility
To reconstitute the lyophilized HIV-1 Nef, it is advised to dissolve it in sterile 18M-cm H2O to a concentration of at least 100 µg/ml. This solution can be further diluted in other aqueous solutions as needed.
Stability
Lyophilized HIV-1 Nef remains stable at room temperature for up to one week. However, for long-term storage, it is recommended to store it desiccated at a temperature below -18°C. Once reconstituted, HIV-1 Nef should be stored at 4°C for a period of 2 to 7 days. For extended storage, it is advisable to add a carrier protein such as 0.1% HSA or BSA. Avoid repeated freeze-thaw cycles.
Purity
High-performance liquid chromatography (HPLC) analysis and SDS-PAGE have determined a purity exceeding 90.0%.
Source
Escherichia Coli.

Product Science Overview

Introduction

The Human Immunodeficiency Virus type 1 (HIV-1) is a major global health concern. Among its various components, the Nef protein plays a crucial role in the virus’s ability to replicate and evade the host’s immune system. The Nef protein is highly conserved across different clades of HIV-1, including Clade B, which is predominant in North America and Europe.

Nef Protein Function

Nef, short for Negative Factor, is an accessory protein that enhances the infectivity of HIV-1. It is involved in several key functions:

  • Downregulation of CD4 and MHC-I molecules: This helps the virus evade the host’s immune response.
  • Activation of Src-family kinases: Nef interacts with host cell proteins, including Src-family kinases, to enhance viral replication .
  • Modulation of apoptosis: Nef can protect infected cells from apoptosis, allowing the virus to persist longer in the host.
Clade B Specifics

Clade B is one of the most studied subtypes of HIV-1. The Nef protein in Clade B has been shown to activate Src-family kinases such as Hck and Lyn, which are crucial for viral replication . This activation is a conserved property across various primary isolates of HIV-1, making it a significant target for antiretroviral therapies.

Recombinant Nef Proteins

Recombinant Nef proteins are engineered versions of the natural protein, often used in research to study the virus’s behavior and to develop vaccines. For instance, a recombinant fusion protein consisting of HIV-1 Clade B antigens, including Nef, has been used in vaccine trials to induce strong immune responses . These recombinant proteins are crucial for understanding the virus’s mechanisms and developing effective treatments.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.